GLENMEDE TRUST CO NA – Vertex Pharmaceuticals Incorporated Transaction History
GLENMEDE TRUST CO NA portfolio value:
$46.24M
portfolio value
GLENMEDE TRUST CO NA quarter portfolio value change:
+2.75%
quarter
Vertex Pharmaceuticals Incorporated 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +1.37% | 2.15K shares | 1.84M | $289.54 | 159.72K |
| Q2 2022 | share | Decrease | -2.11% | -3.40K shares | 2.39M | $281.79 | 157.57K |
| Q1 2022 | share | Increase | +1054.19% | 147.02K shares | 38.94M | $260.97 | 160.97K |
| Q4 2021 | share | Decrease | -8.80% | -1.34K shares | 290K | $222.45 | 13.94K |
| Q3 2021 | share | Increase | +19.48% | 2.49K shares | 193K | $181.39 | 15.29K |
| Q2 2021 | share | Increase | +96.79% | 6.29K shares | 1.18M | $201.63 | 12.79K |
| Q1 2021 | share | Decrease | -90.09% | -59.11K shares | -14.11M | $214.89 | 6.50K |
| Q4 2020 | share | Increase | +1693.30% | 61.95K shares | 14.51M | $236.34 | 65.61K |
| Q3 2020 | share | Increase | +17.69% | 550 shares | 93K | $272.12 | 3.65K |
| Q2 2020 | share | Increase | +23.62% | 594 shares | 351K | $290.31 | 3.10K |
| Q1 2020 | share | 0.00% | 0 shares | 0 | $237.95 | 2.51K | |
| Q4 2019 | share | Decrease | -3.60% | -94 shares | 109K | $218.95 | 2.51K |
| Q3 2019 | share | Increase | +12.60% | 292 shares | 17K | $169.42 | 2.60K |
| Q2 2019 | share | Increase | +21.44% | 409 shares | 74K | $183.38 | 2.31K |
| Q1 2019 | share | Decrease | -12.64% | -276 shares | -11K | $183.95 | 1.90K |
| Q4 2018 | share | Increase | +25.52% | 444 shares | 27K | $165.71 | 2.18K |
| Q3 2018 | share | Increase | +2.72% | 46 shares | 46K | $192.74 | 1.74K |
| Q2 2018 | share | Decrease | -4.88% | -87 shares | 22K | $169.96 | 1.69K |
| Q1 2018 | share | 0.00% | 0 shares | 0 | $162.98 | 1.78K | |
| Q4 2017 | share | Increase | +1.54% | 27 shares | 1K | $149.86 | 1.78K |
| Q3 2017 | share | Increase | +5.98% | 99 shares | 85K | $152.04 | 1.75K |
| Q2 2017 | share | 0.00% | 0 shares | 0 | $128.87 | 1.65K | |
| Q1 2017 | share | Increase | +66.00% | 658 shares | 108K | $109.35 | 1.65K |
| Q4 2016 | share | Decrease | -0.70% | -7 shares | -15K | $73.67 | 997 |
| Q3 2016 | share | Increase | +43.43% | 304 shares | 27K | $87.21 | 1.00K |
| Q2 2016 | share | Increase | +18.04% | 107 shares | 14K | $86.02 | 700 |
| Q1 2016 | share | Decrease | -21.04% | -158 shares | -48K | $79.49 | 593 |